Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction

Por Schwartz, Avery, Blum, Shany, Asleh, Rabea, Pollak, Mordechai, Kalet-Litman, Shiri, Levy, Andrew P
Publicado em 2009

Vitamin E therapy results in a reduction in HDL function in individuals with Diabetes and the Haptoglobin 2-1 genotype

Por Farbstein, Dan, Blum, Shany, Pollak, Mordechai, Asaf, Roy, Lee Viener, Hilla, Lache, Orit, Asleh, Rabea, Miller-Lotan, Rachel, Barkay, Ido, Star, Michael, Schwartz, Avery, Kalet-Littman, Shiri, Ozeri, David, Vaya, Jacob, Tavori, Hagai, Vardi, Moshe, Laor, Arie, Bucher, Stephen E., Anbinder, Yefim, Moskovich, Doron, Abbas, Nur, Perry, Netta, Levy, Yishai, Levy, Andrew P.
Publicado em 2011